MyD88 mutations arise in a number of human malignancies such as Waldenstrom macroglobulinemia (WM), CLL, cutaneous B-cell lymphoma (CBCL), and primary central nervous system lymphoma (PCNSL) [105,106]. This evidence concerns the gene MYD88 and primary central nervous system lymphoma.